FOS and breast cancer: The rapid and sustained downregulation of c-fos and the translocation inhibition of its homodimers AP-1 may contribute to the drug-sensitive effects by activating X-linked inhibitor of apoptosis protein (XIAP) in MCF7 breast cancer cells [119].